期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 117, 期 9, 页码 2506-2516出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI31123
关键词
-
资金
- Intramural NIH HHS Funding Source: Medline
- NCI NIH HHS [P01 CA077839, P01-CA77839] Funding Source: Medline
- NHLBI NIH HHS [R37 HL067330, R37HL67330, P01-HL70694, P01 HL070694] Funding Source: Medline
Sphingosine 1-phosphate (S1P), a multifunctional lipid mediator that signals via the S1P family of G protein-coupled receptors (S1PR), regulates vascular maturation, permeability, and angiogenesis. In this study, we explored the role of SIP 2 receptor (S1P(2)R) in normal vascularization and hypoxia-triggered pathological angiogenesis of the mouse retina. S1P(2)R is strongly induced in ECs during hypoxic stress. When neonatal mice were subjected to ischemia-driven retinopathy, pathologic neovascularization in the vitreous chamber was suppressed in S1p2(-/-) mice concomitant with reduction in endothelial gaps and inflammatory cell infiltration. In addition, EC patterning and normal revascularization into the avascular zones of the retina were augmented. Reduced expression of the proinflammatory enzyme cyclooxygenase-2 (COX-2) and increased expression of eNOS were observed in the S1p2(-/-) mouse retina. S1P(2)R activation in ECs induced COX-2 expression and suppressed the expression of eNOS. These data identify the S1P(2)R-driven inflammatory process as an important molecular event in pathological retinal angiogenesis. We propose that antagonism of the S1P(2)R maybe a novel therapeutic approach for the prevention and/or treatment of pathologic ocular neovascularization.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据